Table 4.

Maximal number of PCILp at relapse (start IFNα), before DLI, during the clinical response, and after a molecular remission was confirmed

Patient	Relapse	DLI	Response	Remission
ES	nt	8	8 (NR)	—
KK	7*	9	98	5†
HG	4	6	26	108‡
EU	10	0	93‡	36
RB	0	0	163‡	5
RV	nt	16	51‡	87‡
WH	0	0	29	0

NR, no response; nt, not tested. 

^*The results are given as number of PCILp per ml of peripheral blood. 

^†Relapse. 

^‡GvHD.